You are here

Morphic Therapeutics

Morphic looks to justify “oral Entyvio” excitement

EP Vantage

Wed, 03/15/23 - 10:04 am

Morphic Therapeutics

ulcerative colitis

AbbVie options integrin-based compounds from Morphic, paving way for potential fibrosis treatments

Endpoints

Tue, 08/25/20 - 10:31 am

Morphic Therapeutics

idiopathic pulmonary fibrosis

Back to business for biotech flotations

EP Vantage

Wed, 07/3/19 - 09:48 am

Turning Point Therapeutics

Stoke Therapeutics

Prevail Therapeutics

NGM Biopharmaceuticals

Akero Therapeutics

Milestone Pharmaceuticals

Morphic Therapeutics

AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance

Xconomy

Thu, 10/18/18 - 11:24 am

Morphic Therapeutics